Blackstone Life Sciences Announces Collaboration to Support Moderna’s Influenza Program
Blackstone announced a new collaboration with Moderna, Inc. through a development and commercialization funding agreement where funds managed by Blackstone Life Sciences will provide up to $750 million to fund Moderna’s influenza program.